Search research articles
Contact Us
Filters
Showing results (41-50 of 82) with videos related to
Page
of 9
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
December 21, 2007
Time and chemotherapy treatment trends in the treatment of elderly patients (age>or=70 years) with non-small cell lung cancer
M E R O'Brien, T Yau, J Coward, et al.
European Journal of Cancer Care
|
November 12, 2015
A randomised assessment of the use of a quality of life questionnaire with or without intervention in patients attending a thoracic cancer clinic
K Nimako, B Ayite, K Priest, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 16, 2010
Histology classification is not a predictor of clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with vinorelbine or gemcitabine combinations
L Trani, J Myerson, S Ashley, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 25, 2014
AKT inhibition synergistically enhances growth-inhibitory effects of gefitinib and increases apoptosis in non-small cell lung cancer cell lines
M Puglisi, P Thavasu, A Stewart, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 9, 2016
A randomised study comparing the effectiveness of acupuncture or morphine versus the combination for the relief of dyspnoea in patients with advanced non-small cell lung cancer and mesothelioma
A Minchom, R Punwani, J Filshie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 2021
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>
S Popat, P Baas, C Faivre-Finn, et al.
British Journal of Cancer
|
July 2, 2014
Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing
S Patton, N Normanno, F Blackhall, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 27, 2016
Mechanism and non-mechanism based imaging biomarkers for assessing biological response to treatment in non-small cell lung cancer
A Weller, M E R O'Brien, M Ahmed, et al.
British Dental Journal
|
May 10, 2014
Oral surgery: ARONJ masterclass
A Moore, T Renton, T Taylor, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
June 18, 2021
Lockdown lessons: The virtual cleft multidisciplinary clinic
A C G Armstrong, J Sibley, G Phippen, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 82) with videos related to
Sort By:
Page
of 9
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
December 21, 2007
Time and chemotherapy treatment trends in the treatment of elderly patients (age>or=70 years) with non-small cell lung cancer
M E R O'Brien, T Yau, J Coward, et al.
European Journal of Cancer Care
|
November 12, 2015
A randomised assessment of the use of a quality of life questionnaire with or without intervention in patients attending a thoracic cancer clinic
K Nimako, B Ayite, K Priest, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 16, 2010
Histology classification is not a predictor of clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with vinorelbine or gemcitabine combinations
L Trani, J Myerson, S Ashley, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 25, 2014
AKT inhibition synergistically enhances growth-inhibitory effects of gefitinib and increases apoptosis in non-small cell lung cancer cell lines
M Puglisi, P Thavasu, A Stewart, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 9, 2016
A randomised study comparing the effectiveness of acupuncture or morphine versus the combination for the relief of dyspnoea in patients with advanced non-small cell lung cancer and mesothelioma
A Minchom, R Punwani, J Filshie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 2021
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>
S Popat, P Baas, C Faivre-Finn, et al.
British Journal of Cancer
|
July 2, 2014
Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing
S Patton, N Normanno, F Blackhall, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 27, 2016
Mechanism and non-mechanism based imaging biomarkers for assessing biological response to treatment in non-small cell lung cancer
A Weller, M E R O'Brien, M Ahmed, et al.
British Dental Journal
|
May 10, 2014
Oral surgery: ARONJ masterclass
A Moore, T Renton, T Taylor, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
June 18, 2021
Lockdown lessons: The virtual cleft multidisciplinary clinic
A C G Armstrong, J Sibley, G Phippen, et al.
Page
of 9